Bharat Biotech enters cell and gene therapy market with $75M production investment: reports
Bharat Biotech is pumping $75 million into a new cell and gene therapy manufacturing facility at the Hyderabad, India, life sciences cluster known as Genome Valley. The move represents the Indian drugmaker's pivot into personalized medicine after years focused largely on vaccines.
Bharat Biotech is pumping $75 million into a new cell and gene therapy manufacturing facility at the Hyderabad, India, life sciences cluster known as Genome Valley. The move represents the Indian drugmaker's pivot into personalized medicine after years focused largely on vaccines.
